XenoGesis will be presenting at the forthcoming event ‘Drug development and clinical trials’ in Barcelona later this month.
The half day session, which is set to take place on the 20th February 2018, is being organised by the Department for International Trade (DIT), in partnership with the Parc Cientific de Barcelona (PCB). It will bring together UK CRO specialists will cover key aspects involved in the successful delivery of pre-clinical development and the effective management of clinical trials.
Richard Weaver’s presentation is entitled ‘Predicting human dose and pharmacokinetics in drug discovery – de-risking projects and maximising success.
For the full programme and details on how to register, click here.